{"id": "1552918235867402240", "edit_history_tweet_ids": ["1552918235867402240"], "created_at": "2022-07-29T07:25:33.000Z", "text": "$abbv Top analyst price target for next week\nhttps://t.co/cvlf6Upiq2", "author_id": "1551402256813412352"}
{"created_at": "2022-07-29T12:31:14.000Z", "text": "$ABBV 2Q solid Immunology but Oncology &amp; Eye Care headwind\nRevenue +4%\n \u2022Humira +6%\n \u2022Humira 37% of revenue\n \u2022Oncology -9%\nNet Income +21%\nDiluted EPS +21% (Adj. +11%) \n\nFY22 guidance\nConfirms 2022 Adjusted Diluted EPS Guidance Range of $13.78 - $13.98\nhttps://t.co/7QKfYfQG1E", "id": "1552995163391270914", "edit_history_tweet_ids": ["1552995163391270914"], "author_id": "1257232763679375365"}
{"text": "RT @chisato_invest: \u30a2\u30c3\u30f4\u30a3 $ABBV 2Q\u6c7a\u7b97\n\n\u274c \u58f2\u4e0a\u9ad8 $14.583B\uff08\u4e88\u60f3 $14.64B\uff09\n\u2319 YoY +4.5%\n\u2b55\ufe0f EPS $3.37\uff08\u4e88\u60f3 $3.31\uff09\n\u2319 YoY +11.2%\n\n\ud83d\udcc9 \u6642\u9593\u5916 -1.17%\n\n\u25b6\ufe0f FY22\u30ac\u30a4\u30c0\u30f3\u30b9\u2026", "edit_history_tweet_ids": ["1553157677399781378"], "created_at": "2022-07-29T23:17:01.000Z", "author_id": "1332201123340382210", "id": "1553157677399781378"}
{"text": "Trending: Health Tech\n\n$ABBV -6.31 %\n$AZN -0.20 %\n$GOVX 49.25 %\n$BHC -9.12 %\n$SRPT 9.37 %\n$SIGA -0.84 %\n$EVFM 5.81 %\n$TLRY -3.15 %\n$THMO 27.76 %\n$INMD -2.37 %\n\nhttps://t.co/WV3qS0l6fi", "author_id": "1448619461892771843", "id": "1553038768072019968", "created_at": "2022-07-29T15:24:31.000Z", "edit_history_tweet_ids": ["1553038768072019968"]}
{"text": "Trending: Pharmaceutical\n\n$ABBV -4.17 %\n$SIGA -18.25 %\n$BHC -10.59 %\n$AZN -1.47 %\n$TNXP -7.49 %\n$LLY -0.51 %\n$ADIL 4.92 %\n$AYLA 20.28 %\n$IRWD -7.51 %\n$ARQT 6.16 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1553155288282419201"], "created_at": "2022-07-29T23:07:31.000Z", "author_id": "1448619461892771843", "id": "1553155288282419201"}
{"text": "$ABBV AbbVie Reports Second-Quarter 2022 Financial Results https://t.co/UMsIKnXkUb", "id": "1553078343678824448", "edit_history_tweet_ids": ["1553078343678824448"], "created_at": "2022-07-29T18:01:46.000Z", "author_id": "4058194633"}
{"id": "1553018500611915777", "text": "Bull Forecasts\nJuly 29, 2022 07:00:00 PDT\n\ud83d\udc02\ud83d\udc02\ud83d\udc02\ud83d\udc02\ud83d\udc02\nticker : log change intraday\n$ORCL : 0.63\n$UPS : 1.13\n$SMH : 1.00\n$DIS : -0.44\n$ABBV : -0.57\n$GS : 0.22\n$OPEN : 0.20\n$WFC : 0.76\n$SU : 0.84\n$FATH : 0.55", "edit_history_tweet_ids": ["1553018500611915777"], "author_id": "1396180686847938560", "created_at": "2022-07-29T14:03:58.000Z"}
{"text": "RT @Dividend_Dollar: Growing Dividends is my love language \n\nHere are 6 of my favorite Dividend Stocks:\n\n$HD Home Depot\n$LOW Lowe\u2019s\n$SBUX S\u2026", "author_id": "904949539085287424", "created_at": "2022-07-29T18:45:44.000Z", "edit_history_tweet_ids": ["1553089406218682370"], "id": "1553089406218682370"}
{"created_at": "2022-07-29T12:36:52.000Z", "text": "RT @ProfesorDiv: $ABBV con un 2Q dentro de lo esperado. Humira sigue creciendo en USA y bajando en el resto del mundo (recordemos que la pa\u2026", "id": "1552996577966530562", "edit_history_tweet_ids": ["1552996577966530562"], "author_id": "214473673"}
{"text": "RT @eWhispers: Friday morning #earnings \n\nhttps://t.co/lObOE0dgsr \n\n$XOM $CVX $PG $ABBV $CL $PSX $AZN $WY $IMO $ENB $ABR $CHTR $ARCB $BLMN\u2026", "id": "1553058837820715009", "edit_history_tweet_ids": ["1553058837820715009"], "created_at": "2022-07-29T16:44:16.000Z", "author_id": "1265418869633478656"}
{"id": "1553015212382769152", "text": "$ABBV ~`Everyone is Buying the Dip Right Now...Hoarding Shares.. https://t.co/Rwll2f1tGl", "edit_history_tweet_ids": ["1553015212382769152"], "author_id": "1522885051259576320", "created_at": "2022-07-29T13:50:54.000Z"}
{"text": "Stock: $ABBV - AbbVie Inc.\n*** NEWS ***\nABBV Stock Slips as AbbVie Faces Opioid Lawsuits - InvestorPlace\nhttps://t.co/P3ywt2Bk2e\nTry now the Best Pivot Point Calculator!! https://t.co/CFmq8XtjCj\n#tradingview\n#stocks\n#stockstowatch https://t.co/KzRjDamKxU", "edit_history_tweet_ids": ["1553140838791782400"], "created_at": "2022-07-29T22:10:06.000Z", "author_id": "3114448031", "id": "1553140838791782400"}
{"text": "Trending: S&amp;P 500\n\n$TWTR 0.51 %\n$INTC -10.11 %\n$CVX 8.15 %\n$AMZN 10.55 %\n$AAPL 2.18 %\n$ABBV -6.50 %\n$AON 0.19 %\n$WY -1.07 %\n$AMD 0.43 %\n$SCHW 2.30 %\n\nhttps://t.co/WV3qS0l6fi", "author_id": "1448619461892771843", "id": "1553042245238022145", "created_at": "2022-07-29T15:38:20.000Z", "edit_history_tweet_ids": ["1553042245238022145"]}
{"text": "RT @unusual_whales: Earnings today!\n\nPremarket:\n$XOM\n$PG\n$CVX\n$ABBV\n$AZN\n$SONY\n$CHTR\n$ENB\n$AON\n$PXS\n$CHT\n$ES\n$NWG\n$LYB\n$IMO\n$WY\n$GWW\n$CHD\n$\u2026", "id": "1553067317784870916", "edit_history_tweet_ids": ["1553067317784870916"], "created_at": "2022-07-29T17:17:57.000Z", "author_id": "1263338419264110592"}
{"text": "RT @JesseCohenInv: Happy Friday!\n\n*Here Are My #Top5ThingsToKnowToday:\n\n- Stocks Set For Higher Open\n- $AMZN $AAPL Jump On Guidance\n- $XOM\u2026", "id": "1553069494330949634", "edit_history_tweet_ids": ["1553069494330949634"], "created_at": "2022-07-29T17:26:36.000Z", "author_id": "1372254265029365762"}
{"id": "1552976711830085632", "edit_history_tweet_ids": ["1552976711830085632"], "created_at": "2022-07-29T11:17:55.000Z", "text": "Trending: S&amp;P 500\n\n$INTC -10.40 %\n$TWTR -0.34 %\n$AMZN 12.90 %\n$ABBV 0.30 %\n$CVX 3.60 %\n$PG -3.59 %\n$WY 0.36 %\n$AON 0.00 %\n$QCOM -0.12 %\n$GOOGL 0.69 %\n\nhttps://t.co/WV3qS0l6fi", "author_id": "1448619461892771843"}
{"text": "Trending: Health Tech\n\n$GOVX 36.68 %\n$ABBV -4.16 %\n$SIGA -17.94 %\n$THMO 8.48 %\n$BHC -9.80 %\n$MRNA 3.75 %\n$AZN -0.78 %\n$TNXP -7.49 %\n$SRPT 7.94 %\n$LLY -1.19 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1553132797694443522"], "created_at": "2022-07-29T21:38:09.000Z", "author_id": "1448619461892771843", "id": "1553132797694443522"}
{"text": "DailyDown5\n$ABBV $140.94 -5.88% -5.07% -7.57% -9.83% 32.13\n$BABA $91.04 -9.46% -9.51% -22.03% 6.06% 32.48\n$BLI $4.39 -6.69% -2.77% -11.03% -22.21% 44.57\n$CMCSA $37.09 -5.89% -12.93% -5.21% -18.86% 33.03\n$COTY $7.29 -5.81% -6.54% -8.88% -11.74% 44.52", "id": "1553065165037387778", "edit_history_tweet_ids": ["1553065165037387778"], "created_at": "2022-07-29T17:09:24.000Z", "author_id": "1259215707817955328"}
{"text": "Trending: S&amp;P 500\n\n$TWTR 1.39 %\n$AAPL 3.11 %\n$INTC -9.02 %\n$AMD 3.17 %\n$AMZN 10.27 %\n$CVX 8.85 %\n$NVDA 1.00 %\n$JPM 0.54 %\n$ABBV -4.20 %\n$GOOGL 1.64 %\n\nhttps://t.co/WV3qS0l6fi", "edit_history_tweet_ids": ["1553144285595303936"], "created_at": "2022-07-29T22:23:48.000Z", "author_id": "1448619461892771843", "id": "1553144285595303936"}
{"created_at": "2022-07-29T13:01:40.000Z", "text": "Trending: Pharmaceutical\n\n$ABBV -1.50 %\n$AZN 0.00 %\n$SIGA -0.45 %\n$PHGE -10.75 %\n$BMY -0.80 %\n$TNXP -2.14 %\n$CTLT 0.13 %\n$BHC 9.22 %\n$FREQ 4.90 %\n\nhttps://t.co/WV3qS0l6fi", "id": "1553002820160430082", "edit_history_tweet_ids": ["1553002820160430082"], "author_id": "1448619461892771843"}
{"text": "RT @MarketRebels: Earnings tomorrow: \n\n$XOM Exxon Mobil \n$CVX Chevron \n$ABBV AbbVie", "author_id": "2342034456", "id": "1552850256538308615", "created_at": "2022-07-29T02:55:26.000Z", "edit_history_tweet_ids": ["1552850256538308615"]}
{"text": "$ABBV  new alert at https://t.co/A7qrDarJHY  #stocks #daytrading  #NYSE #NASDAQ #market 1574", "author_id": "39546678", "id": "1552898006818738177", "created_at": "2022-07-29T06:05:10.000Z", "edit_history_tweet_ids": ["1552898006818738177"]}
{"text": "these are the trending stocks $AMZN  $INTC  $ROKU  $BABA  $ABBV  $XOM  $CVX", "author_id": "1358336778479022081", "created_at": "2022-07-29T18:20:03.000Z", "edit_history_tweet_ids": ["1553082944599777288"], "id": "1553082944599777288"}
{"text": "RT @MarketRebels: $ABBV down over -6% on the day, on pace for largest percent decrease since September 2021.", "author_id": "1214403876188827648", "created_at": "2022-07-29T18:20:57.000Z", "edit_history_tweet_ids": ["1553083172434444288"], "id": "1553083172434444288"}
{"text": "$ABBV RINVOQ\u00ae (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis\n \nhttps://t.co/heARkG5FKr", "author_id": "1393303407801294850", "id": "1552896769301684226", "created_at": "2022-07-29T06:00:15.000Z", "edit_history_tweet_ids": ["1552896769301684226"]}
